Mirae Asset Global Etfs Holdings Ltd. Denali Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 134,703 shares of DNLI stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,703
Previous 88,507
52.19%
Holding current value
$2.08 Million
Previous $1.2 Million
56.61%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DNLI
# of Institutions
247Shares Held
135MCall Options Held
148KPut Options Held
15.4K-
Black Rock Inc. New York, NY13.2MShares$203 Million0.01% of portfolio
-
Baillie Gifford & CO12MShares$184 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$182 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.58MShares$101 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.26MShares$96.6 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.07B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...